For laboratory research use only (in vitro). Not for human or animal use.
| Quantity | Discount | Unit Price |
|---|---|---|
| 1-2 units | Standard | $67.99 |
| 3-4 units | 5% off | $64.59 |
| 5-9 units | 10% off | $61.19 |
| 10+ units Best Value | 15% off | $57.79 |
Why researchers choose PBC:
Accepted payment methods:
Certificate of Analysis available upon request. Contact us for lot-specific documentation.
| Amino Acid Sequence | Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
|---|---|
| Molecular Weight | 1025.18 Da |
| Molecular Formula | C50H68N14O10 |
| CAS Number | 189691-06-3 |
| Purity | ≥98% (HPLC) |
| Format | Lyophilized Powder |
| Net Quantity | 10mg |
| Vials Per Kit | 10 |
| Storage | Store at -20C. Reconstituted: 2-8C |
| Research Status | Approved |
For laboratory research use only (in vitro). Not for human or animal use.
PT-141 analytical reference compound. Molecular weight 1025.18 Da.
| Sequence | Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular Weight | 1025.18 Da |
| Molecular Formula | C50H68N14O10 |
| CAS | 189691-06-3 |
| Purity | >=98% (HPLC) |
| Format | Lyophilized powder |
| Storage | Store at -20C. Reconstituted: 2-8C |
For laboratory research use only (in vitro). Not for human or animal use.
5 references
References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA (2019). Obstetrics and Gynecology. PubMed 31599840
Safety Profile of Bremelanotide Across the Clinical Development Program
Clayton AH, Kingsberg SA, Portman D, Sadiq A, Krop J, Jordan R, Lucas J, Simon JA (2022). Journal of Women's Health. PubMed 35147466
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women
Pfaus JG, Sadiq A, Spana C, Clayton AH (2022). CNS Spectrums. PubMed 33455598
Melanocortins in the treatment of male and female sexual dysfunction
Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ (2007). Current Topics in Medicinal Chemistry. PubMed 17584134
Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder
Mayer D, Lynch SE (2020). Annals of Pharmacotherapy. PubMed 31893927
For laboratory research use only (in vitro). Not for human or animal use.